ASTM E3326

ASTM E3326 is the standard guide for application of Continuous Manufacturing (BioCM) in the biopharmaceutical industry. It provides a structured reference for understanding how continuous manufacturing approaches may be applied in biopharmaceutical operations, helping organizations align process design, implementation, and evaluation with a recognized ASTM standard. For teams working to improve consistency and control in biologics production, this guide can support clearer decision-making and more reliable technical communication.

What is ASTM E3326?

ASTM E3326 is a guide, not a prescriptive process specification, focused on the application of continuous manufacturing in the biopharmaceutical industry. Its technical context is the adoption of BioCM approaches, where production steps are arranged for ongoing operation rather than batch-by-batch processing. As an ASTM standard, it is intended to help users frame how continuous manufacturing may be applied, considered, and documented in a biopharmaceutical setting. ASTM E3326 is therefore useful as a reference for planning and evaluating BioCM implementation.

Where is ASTM E3326 used?

This guide is commonly used in biopharmaceutical development and manufacturing environments where continuous processing is being explored or introduced. It may be relevant to production teams, process engineering groups, quality functions, and technical staff involved in BioCM workflows. The standard is especially useful when organizations need a shared framework for discussing continuous manufacturing concepts, aligning internal practices, or supporting technical review of biopharmaceutical process strategies. ASTM E3326 can also help when comparing implementation approaches across facilities or projects.

Why is ASTM E3326 important?

ASTM E3326 matters because continuous manufacturing in biopharmaceutical production requires consistent terminology, practical guidance, and a common technical basis for evaluation. A recognized guide can support compliance efforts, reduce ambiguity during procurement or project planning, and strengthen quality control discussions around process application. For organizations assessing BioCM, ASTM E3326 may help lower implementation risk by providing a structured reference for planning, review, and communication. It is especially valuable where consistency and traceability are important.

• Guide for BioCM application
• Biopharmaceutical industry focus
• Supports process planning and review
• Useful for technical and quality teams
• Helps align continuous manufacturing discussions